BioCentury
ARTICLE | Company News

Alnylam chemistry news

July 14, 2008 7:00 AM UTC

Following initial proceedings, the Opposition Division of the European Patent Office (EPO) overturned the claims of Alnylam’s European Patent No. EP1230375, which covers RNAi technology including inhi...